Stay updated on IDO Inhibitor with Checkpoint Inhibitors for Melanoma Clinical Trial
Sign up to get notified when there's something new on the IDO Inhibitor with Checkpoint Inhibitors for Melanoma Clinical Trial page.

Latest updates to the IDO Inhibitor with Checkpoint Inhibitors for Melanoma Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoChange DetectedThe page's revision tag was updated from v3.6.3 to v3.6.4, signaling a minor update to the page template or platform. This update does not modify the study details or user-facing information.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe study documents revision label was updated from v3.6.2 to v3.6.3, indicating a newer revision of the materials.SummaryDifference0.0%

- Check39 days agoChange DetectedThe page shows a revision tag updated from v3.6.0 to v3.6.2, signaling a metadata update to the study record on ClinicalTrials.gov.SummaryDifference0.0%

- Check54 days agoChange DetectedRecruitment is now indicated as no longer looking for participants. The page also adds guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the revision to v3.6.0, signaling updated navigation and documentation.SummaryDifference0.4%

- Check61 days agoChange DetectedRevision updated from v3.5.4 to v3.5.5, indicating a small release update to the page's underlying versioning. This update does not alter the displayed study details.SummaryDifference0.0%

- Check68 days agoChange DetectedThe page now shows that results were posted (May 29, 2026) with primary and secondary outcome data, along with links to sponsor information and supporting documents (protocol and statistical analysis plan).SummaryDifference3%

Stay in the know with updates to IDO Inhibitor with Checkpoint Inhibitors for Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IDO Inhibitor with Checkpoint Inhibitors for Melanoma Clinical Trial page.